Ask Warren

Orum Therapeutics

475830 · KOSDAQ · ₩475830 · 오름테라퓨틱

₩16,360▲ ₩290 (1.80%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 29, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과

    Predicted impact: Low

    Oct 23, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고

    Predicted impact: Low

    Stock option grant filing; size not given and such grants are routine for biotech firms.

    Oct 23, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고

    Predicted impact: Low

    Independent director appointment or change, likely tied to the shareholders' meeting already reported in recent days.

    Oct 23, 2026Open on DART
  • Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 21, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Oct 8, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (Bristol Myers Squibb(BMS)의 BMS-986497(ORM-6151) 임상 중단에 따른 자산양수도 계약 종료)Sep 17, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Sep 10, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의 (임시주주총회)Sep 10, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Aug 31, 2026Open on DART
  • Adjustment of Conversion Price for Convertible Shares (Convertible Preferred Shares)전환주식의전환가액조정 (전환우선주)Aug 18, 2026Open on DART
  • Adjustment of Conversion Price for Convertible Shares (Convertible Preferred Shares)전환주식의전환가액조정 (전환우선주)Aug 14, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Jul 6, 2026Open on DART
  • Amended: Investor relations (IR) event[기재정정]기업설명회(IR)개최Jun 29, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Jun 29, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Jun 29, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Jun 19, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Jun 10, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 9, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 9, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 9, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • [Amended] Exercise of Stock Purchase Options[기재정정]주식매수선택권행사Apr 8, 2026Open on DART
  • Exercise of Stock Purchase Options주식매수선택권행사Apr 1, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 31, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 31, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 30, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 27, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 26, 2026Open on DART
  • Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 26, 2026Open on DART
  • Amended: Audit report submitted[기재정정]감사보고서제출Mar 19, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 19, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 12, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
  • Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 5, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 5, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 5, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Feb 19, 2026Open on DART
  • Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Jan 28, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jan 23, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jan 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jan 16, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jan 13, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 8, 2026Open on DART
  • Amended attachment: Rights offering (paid-in capital increase) decision[첨부정정]주요사항보고서(유상증자결정)Jan 8, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Dec 18, 2025Open on DART

Titles in Korean until English translations are added.

Also known as: Orum Therapeutics / 오름테라퓨틱 / 475830 / KRX:475830

Source: KRX statistical information